Unknown

Dataset Information

0

Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.


ABSTRACT: Exosomal miRNAs are proposed as excellent candidate biomarkers for clinical applications. However, little is known about their potential roles as prognostic biomarkers in lung cancer. In this study, we explored the prognostic value of plasma exosomal microRNAs (miRNAs) for non-small-cell lung cancer (NSCLC). Using a quantitative polymerase chain reaction (qPCR) array panel, we analyzed 84 plasma exosomal miRNAs in 10 lung adenocarcinoma patients and 10 matched healthy controls. The qPCR array showed 30 aberrantly expressed exosomal miRNAs. Nine candidate miRNAs were selected based on differential expression and previous reports for further evaluating their prognostic roles in 196 NSCLC patients. Elevated levels of exosomal miR-23b-3p, miR-10b-5p and miR-21-5p were independently associated with poor overall survival (with hazard ratio [95% confidence interval]: 2.42 (1.45 - 4.04), P = 0.001; 2.22 (1.18 - 4.16), P = 0.013; 2.12 (1.28 - 3.49), P = 0.003, respectively). When compared to the clinical prognostic variables only model, adding the three exosomal miRNA signatures significantly improved survival predictive accuracy with an increase of time-dependent area under the receiver operating characteristic curve from 0.88 to 0.91 (P=0.015). Our results indicated that plasma exosomal miR-23b-3p, miR-10b-5p and miR-21-5p are promising non-invasive prognostic biomarkers of NSCLC.

SUBMITTER: Liu Q 

PROVIDER: S-EPMC5355076 | BioStudies | 2017-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC6355644 | BioStudies
2017-01-01 | S-EPMC5642528 | BioStudies
2020-01-01 | S-EPMC7592397 | BioStudies
| S-EPMC7405601 | BioStudies
2015-01-01 | S-EPMC4591334 | BioStudies
1000-01-01 | S-EPMC4356518 | BioStudies
2020-01-01 | S-EPMC7089961 | BioStudies
| S-EPMC6407000 | BioStudies
2020-01-01 | S-EPMC7761501 | BioStudies
2017-01-01 | S-EPMC5606074 | BioStudies